|
Meta-analysis of kidney-tonifying therapy for
infantile bronchial asthma in remission period
PAN Yushuo, SHU Pei, QU Nini
2022, 14 (1):
61-67.
ObjectiveTo evaluate
the efficacy and safety of kidney-tonifying in the
treatment of bronchial asthma in children in remission period.MethodsCochrane
Library, Embase, PubMed, CBM, CNKI, Weipu and Wanfang databases were searched
through computers for randomized controlled trials(RCTs) on the treatment of
childhood bronchial asthma in remission period, and RevMan 5.3 software was
used to evaluate the quality of the included literatures and Meta analysis was
made.ResultsTotally 13 RCTs were finally included, with a total of 1 182
patients, 591 in the experimental group and 591 in the control group. Meta-analysis results showed that kidney-tonifying therapy for bronchial asthma in children could improve the
clinical efficacy[Z=6.14,OR=4.75,95%CI(2.89,7.81),P<0.000 01]; the level of peak
expiratory flow rate(PEF) of lung function[Z=3.61, MD=0.63,
95%CI(0.29, 0.97), P=0.000 3]; forced vital capacity(FEV1) level in the first second of lung function[Z=4.08, MD=0.21,
95%CI (0.11,0.31),P<0.000 1]; Serum IgA level[Z=6.82,MD=0.22,95%CI(0.16,0.29),P<0.000 01]; Serum IgG level[Z=11.88,MD=1.71,95%CI(1.43,1.99),P<0.000
01]; Serum IgM level[Z=4.70,MD=0.18,95%CI(0.11,0.26),P<0.000
01]; Inflammatory factor
IgE level[Z=5.39, MD=-28.13, 95%CI(-38.36,-17.90), P<0.000 01]; the level of
inflammatory factor IL-4[Z= 15.22, MD=-5.33,
95%CI(-6.02,-4.64),P<0.000 01]; the level of
inflammatory factor IFN-γ[Z=6.62,
MD=1.69,95%CI(1.19,2.19),P<0.000 01]. Three studies
clearly showed that no obvious adverse reactions occurred, and the rest of the
literatures did not mention it. ConclusionExisting data show that the Kidney-tonifying therapy in the treatment of infantile asthma in the remission
period is effective in improving the level of lung function, increasing the
serum IgA, IgG, IgM, reducing the level of inflammatory factors IgE, and
regulating the level of IL-4/IFN-γ.
Related Articles |
Metrics
|